Screener
Protagonist Therapeutics PTGX Free cash flow margin
Discontinued — last reported Q1 '23
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Protagonist Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Protagonist Therapeutics’s 10-Q, filed May 7, 2024. Open the filing →
- Filed
- May 7, 2024
- Fiscal quarter
- Q1 FY2024
- Calendar quarter
- Q1 2024
- Accession
- 0001558370-24-007081
FAQ
- What is Protagonist Therapeutics's free cash flow margin?
- Protagonist Therapeutics (PTGX) reported free cash flow margin of -12,264.3% in Q1 2023.
- How has Protagonist Therapeutics's free cash flow margin changed year-over-year?
- Protagonist Therapeutics's free cash flow margin decreased by 4773.1% year-over-year, from -251.7% to -12,264.3%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.
Ask your AI about Protagonist Therapeutics's free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude